Researchers have successfully deployed a Zika virus vaccine to target and kill human glioblastoma brain cancer stem cells, which had been transplanted into mice. In a new study, the team shows that a live, attenuated version of the Zika virus could form the basis of a new treatment option for this fatal brain cancer.
Become a Member!
– All SoP monthly magazines
– All NPT magazine archives (63 issues)
– Assorted reading and video courses
– Discounts and access to select webinars and special events
*All pricing in USD.